Saxonov Serge's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 900 Class A Common Stock done . Disclosure was reported to the exchange on Sept. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Sep 2025 | 900 | 1,034,817 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.79 per share. | 22 Aug 2025 | 9,348 | 945,892 (4%) | 0% | 13.8 | 128,881 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jun 2025 | 1,000 | 955,240 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 3,000 | 1,080,625 (5%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.30 per share. | 22 May 2025 | 9,343 | 1,083,625 (5%) | 0% | 8.3 | 77,540 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 171,428 | 1,092,968 (5%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 50,000 | 17,463 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 28 Feb 2025 | 50,000 | 921,540 (4%) | 0% | 1.2 | 60,000 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.63 per share. | 28 Feb 2025 | 7,942 | 871,540 (4%) | 0% | 10.6 | 84,393 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 24 Feb 2025 | 5,092 | 879,482 (4%) | 0% | 11.1 | 56,346 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 23 Dec 2024 | 12,000 | 884,574 (4%) | 0% | 1.2 | 14,400 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 12,000 | 67,463 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.69 per share. | 21 Nov 2024 | 6,693 | 872,574 (4%) | 0% | 13.7 | 91,612 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2024 | 1,850 | 879,267 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Nov 2024 | 1,350 | 881,117 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.53 per share. | 22 Aug 2024 | 6,749 | 882,467 (4%) | 0% | 22.5 | 152,053 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2024 | 425 | 889,216 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 24.30 per share. | 22 May 2024 | 4,877 | 889,641 (4%) | 0% | 24.3 | 118,529 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 88,854 | 894,518 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2024 | 1,086 | 805,664 (3%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 04 Mar 2024 | 4,660 | 842,900 (3%) | 0% | 44.0 | 205,021 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Saxonov Serge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.34 per share. | 22 Feb 2024 | 2,821 | 847,560 (3%) | 0% | 46.3 | 130,737 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Saxonov Serge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.58 per share. | 15 Feb 2024 | 3,300 | 852,081 (4%) | 0% | 48.6 | 160,300 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.43 per share. | 15 Feb 2024 | 1,700 | 850,381 (3%) | 0% | 49.4 | 84,032 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.53 per share. | 09 Feb 2024 | 1,000 | 855,381 (4%) | 0% | 49.5 | 49,530 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Saxonov Serge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.10 per share. | 16 Jan 2024 | 2,965 | 857,416 (4%) | 0% | 45.1 | 133,712 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.65 per share. | 16 Jan 2024 | 1,035 | 856,381 (4%) | 0% | 45.6 | 47,244 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 27 Dec 2023 | 14,935 | 860,381 (4%) | 0% | 1.2 | 17,922 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Saxonov Serge | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 14,935 | 79,463 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Saxonov Serge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.15 per share. | 14 Dec 2023 | 1,700 | 845,446 (3%) | 0% | 55.1 | 93,749 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.39 per share. | 14 Dec 2023 | 300 | 847,146 (3%) | 0% | 54.4 | 16,316 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.78 per share. | 22 Aug 2023 | 3,757 | 864,093 (4%) | 0% | 45.8 | 172,000 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.10 per share. | 14 Aug 2023 | 1,983 | 867,867 (4%) | 0% | 50.1 | 99,355 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.41 per share. | 14 Aug 2023 | 17 | 867,850 (4%) | 0% | 50.4 | 857 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.03 per share. | 19 Jul 2023 | 40,000 | 869,850 (4%) | 0% | 60.0 | 2,401,088 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 20,845 | 32,478 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 19 Jul 2023 | 20,845 | 909,850 (4%) | 0% | 5.0 | 105,059 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.37 per share. | 14 Jul 2023 | 1,149 | 889,005 (4%) | 0% | 58.4 | 67,064 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.61 per share. | 14 Jul 2023 | 851 | 890,154 (4%) | 0% | 57.6 | 49,026 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.53 per share. | 14 Jun 2023 | 1,209 | 891,056 (4%) | 0% | 58.5 | 70,758 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 14 Jun 2023 | 740 | 892,265 (4%) | 0% | 57.5 | 42,553 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jun 2023 | 185 | 893,005 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.16 per share. | 14 Jun 2023 | 51 | 891,005 (4%) | 0% | 59.2 | 3,017 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 19 May 2023 | 2,068 | 893,190 (4%) | 0% | 55.1 | 113,867 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 19 May 2023 | 534 | 895,258 (4%) | 0% | 55.1 | 29,404 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 May 2023 | 460 | 27 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 53.57 per share. | 15 May 2023 | 1,506 | 895,792 (4%) | 0% | 53.6 | 80,669 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 52.70 per share. | 15 May 2023 | 494 | 897,298 (4%) | 0% | 52.7 | 26,032 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 53.61 per share. | 14 Apr 2023 | 1,641 | 898,151 (4%) | 0% | 53.6 | 87,976 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.64 per share. | 14 Apr 2023 | 283 | 897,868 (4%) | 0% | 54.6 | 15,462 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.28 per share. | 14 Apr 2023 | 76 | 897,792 (4%) | 0% | 55.3 | 4,201 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 72,773 | 72,773 | - | - | Performance - based Restricted Stock Units | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 72,773 | 72,773 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 36,387 | 899,792 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.81 per share. | 14 Mar 2023 | 1,697 | 863,708 (4%) | 0% | 48.8 | 82,824 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.28 per share. | 14 Mar 2023 | 303 | 863,405 (4%) | 0% | 49.3 | 14,932 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2023 | 260 | 487 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 47.75 per share. | 22 Feb 2023 | 1,941 | 909,715 (4%) | 0% | 47.8 | 92,689 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 12 Dec 2022 | 3,000 | 911,656 (4%) | 0% | 1.2 | 3,600 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 3,000 | 38,035 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2022 | 1,740 | 747 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 1,887 | 974,926 (4%) | 0% | 34.1 | 64,281 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 34.06 per share. | 22 Nov 2022 | 789 | 976,813 (4%) | 0% | 34.1 | 26,877 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 213,112 | 213,112 | - | - | Performance-based Restricted Stock Units | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 142,075 | 142,075 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2022 | 11,500 | 41,035 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 12 Sep 2022 | 11,500 | 977,602 (4%) | 0% | 1.2 | 13,800 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.19 per share. | 23 Aug 2022 | 2,715 | 966,102 (4%) | 0% | 35.2 | 95,544 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jun 2022 | 1,651 | 2,487 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.76 per share. | 23 May 2022 | 2,656 | 968,817 (4%) | 0% | 48.8 | 129,516 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 146,827 | 146,827 | - | - | Stock Option (Right to Buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 58,731 | 971,473 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 78.60 per share. | 22 Feb 2022 | 551 | 912,742 (4%) | 0% | 78.6 | 43,309 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 90.30 per share. | 08 Feb 2022 | 4,503 | 915,690 (4%) | 0% | 90.3 | 406,618 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 89.19 per share. | 08 Feb 2022 | 4,200 | 920,193 (4%) | 0% | 89.2 | 374,590 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 3,038 | 42,521 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 08 Feb 2022 | 3,038 | 925,293 (4%) | 0% | 11.5 | 34,876 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 91.04 per share. | 08 Feb 2022 | 2,397 | 913,293 (4%) | 0% | 91.0 | 218,228 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 88.17 per share. | 08 Feb 2022 | 900 | 924,393 (4%) | 0% | 88.2 | 79,349 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 140.96 per share. | 04 Jan 2022 | 5,368 | 927,787 (4%) | 0% | 141.0 | 756,663 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 139.82 per share. | 04 Jan 2022 | 3,100 | 933,155 (4%) | 0% | 139.8 | 433,444 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 04 Jan 2022 | 3,037 | 937,255 (4%) | 0% | 11.5 | 34,865 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 3,037 | 45,559 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 141.72 per share. | 04 Jan 2022 | 2,932 | 924,855 (4%) | 0% | 141.7 | 415,517 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 144.78 per share. | 04 Jan 2022 | 1,400 | 922,755 (4%) | 0% | 144.8 | 202,695 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 138.86 per share. | 04 Jan 2022 | 1,000 | 936,255 (4%) | 0% | 138.9 | 138,864 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 143.11 per share. | 04 Jan 2022 | 700 | 924,155 (4%) | 0% | 143.1 | 100,179 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 145.33 per share. | 04 Jan 2022 | 500 | 922,255 (4%) | 0% | 145.3 | 72,663 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 28 Dec 2021 | 56,363 | 934,218 (4%) | 0% | 1.2 | 67,636 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 56,363 | 52,535 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2021 | 360 | 4,138 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 147.05 per share. | 07 Dec 2021 | 6,480 | 880,979 (4%) | 0% | 147.0 | 952,882 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 5,209 | 53,323 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 07 Dec 2021 | 5,209 | 889,818 (4%) | 0% | 5.0 | 26,253 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 143.36 per share. | 07 Dec 2021 | 3,187 | 888,702 (4%) | 0% | 143.4 | 456,881 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 3,037 | 48,596 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 07 Dec 2021 | 3,037 | 892,855 (4%) | 0% | 11.5 | 34,865 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 147.96 per share. | 07 Dec 2021 | 2,370 | 878,609 (4%) | 0% | 148.0 | 350,673 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 142.40 per share. | 07 Dec 2021 | 766 | 891,889 (4%) | 0% | 142.4 | 109,075 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.60 per share. | 07 Dec 2021 | 754 | 877,855 (4%) | 0% | 148.6 | 112,043 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 144.27 per share. | 07 Dec 2021 | 672 | 888,030 (4%) | 0% | 144.3 | 96,950 | Class A Common Stock |